Today: 30 June 2026
Rocket Lab stock slides on KeyBanc downgrade: what investors are watching for RKLB next
15 January 2026
1 min read

Rocket Lab stock slides on KeyBanc downgrade: what investors are watching for RKLB next

New York, Jan 15, 2026, 10:55 EST — Regular session

  • Shares of Rocket Lab dropped roughly 4% in early trading following a downgrade from KeyBanc
  • The broker noted that Rocket Lab’s multi-year growth drivers have become common knowledge
  • Attention now shifts to the Neutron launch schedule and earnings set for late February

Rocket Lab shares slipped Thursday following a downgrade from KeyBanc Capital Markets, halting a recent surge that had lifted the stock to new highs this month. The stock dropped roughly 4.3% to $87.90 in early trading.

The stock closed Wednesday 6% higher at $91.80, fueling a sharp rally that attracted both quick traders and longer-term defense and space investors. On Thursday, it gave back some of those gains.

Rocket Lab has surged roughly 63% in the past month and climbed over 250% in the past year, according to TradingView data. With such lofty gains, even minor setbacks can pack a punch.

KeyBanc downgraded Rocket Lab from “overweight” to “sector weight” and left the price target off the table, according to TheFly. In brokerage terms, “sector weight” roughly means neutral, compared with “overweight,” which suggests the stock should outperform. TipRanks

The brokerage noted that Rocket Lab’s long-term growth drivers are “well known” at this point, calling the near- to medium-term risk-reward fairly balanced. It flagged the possibility of becoming more bullish if there’s clearer timing on Neutron’s maiden flight, bigger contract wins, or a stronger-than-anticipated boost in its space systems segment. Benzinga

Rocket Lab’s recent momentum reflects growing confidence in its government contracts. On Dec. 19, the company announced securing an $816 million deal from the Space Development Agency to produce 18 missile-warning and tracking satellites. The contract includes a base amount of $806 million, with options adding up to $10.45 million. CEO Peter Beck described the win as an honor to contribute to the program.

The SDA handed out roughly $3.5 billion tied to that tranche, awarding contracts to Lockheed Martin, L3Harris Technologies, and Northrop Grumman, Reuters reported. These satellites aim to track missile threats worldwide from low Earth orbit.

Despite the stock’s recent rally, some analysts remain upbeat. Cantor Fitzgerald reaffirmed its overweight rating on Wednesday, highlighting Neutron’s maiden flight planned for the first half of 2026 as a major driver for the shares, according to a note summarized by Benzinga.

Neutron’s timeline has already faced setbacks. On a November earnings call, Beck revealed Rocket Lab had delayed the rocket’s maiden flight to 2026. Delays continue to be a major execution risk for the company’s stock.

Rocket Lab’s quarterly earnings, expected Feb. 26 after the close, will be the next key moment. MarketBeat is forecasting this report. Investors will zero in on progress with Neutron, how backlog is turning into revenue, and any fresh guidance on the pace of new contract wins.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Inflation Fears Look Overdone, Fed Chief Warsh Tones Down Hawkish Talk
    June 30, 2026, 9:52 AM EDT. Inflation worries seem bigger than the data shows, with price gains coming in softer than many think. Federal Reserve Chair Kevin Warsh, usually known for tough talk on rates, took a softer line. Some analysts say markets have read too much into the outlook for rate hikes, which could keep the stock market steady. Investors are working through mixed economic messages.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop